Cargando…
Molecular Imaging of Hepatocellular Carcinoma Xenografts with Epidermal Growth Factor Receptor Targeted Affibody Probes
Hepatocellular carcinoma (HCC) is a highly aggressive and lethal cancer. It is typically asymptomatic at the early stage, with only 10%–20% of HCC patients being diagnosed early enough for appropriate surgical treatment. The delayed diagnosis of HCC is associated with limited treatment options and m...
Autores principales: | Zhao, Ping, Yang, Xiaoyang, Qi, Shibo, Liu, Hongguang, Jiang, Han, Hoppmann, Susan, Cao, Qizhen, Chua, Mei-Sze, So, Samuel K., Cheng, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654646/ https://www.ncbi.nlm.nih.gov/pubmed/23710458 http://dx.doi.org/10.1155/2013/759057 |
Ejemplares similares
-
Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patient-derived xenografts
por: Wei, Wei, et al.
Publicado: (2014) -
Fluorogen Activating Protein–Affibody Probes:
Modular, No-Wash Measurement of Epidermal Growth Factor Receptors
por: Wang, Yi, et al.
Publicado: (2014) -
Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts
por: Garousi, Javad, et al.
Publicado: (2019) -
Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake
por: Rosestedt, Maria, et al.
Publicado: (2019) -
A Humanized Anti-GPC3 Antibody for Immuno-Positron Emission Tomography Imaging of Orthotopic Mouse Model of Patient-Derived Hepatocellular Carcinoma Xenografts
por: Natarajan, Arutselvan, et al.
Publicado: (2021)